Literature DB >> 34925080

Consequences of the COVID-19 Pandemic on Children's Mental Health: A Meta-Analysis.

Eve-Line Bussières1, Catherine Malboeuf-Hurtubise2, A Meilleur3, Trinity Mastine2, Elodie Hérault4, Nicholas Chadi5, Marjorie Montreuil6, Mélissa Généreux7, Chantal Camden7.   

Abstract

Background: The COVID-19 pandemic has exacerbated mental health problems in many individuals, including children. Children with pre-existing socio-demographic or developmental risk factors may be particularly vulnerable to the negative effects of the pandemic and associated public health preventive measures. Objective: This systematic review and meta-analysis explored the impacts of the COVID-19 pandemic on the mental health of children aged 5-13 years-old, while highlighting the specific difficulties experienced by children with neurodevelopmental issues or chronic health conditions.
Methods: A systematic search of the published literature was conducted in Medline, ERIC, PsycINFO, and Google Scholar, followed by a quantitative meta-analysis of the eligible studies.
Results: Out of the 985 articles identified, 28 empirical studies with prospective or retrospective longitudinal data were included in the quantitative synthesis. COVID-19 lockdown measures were associated with negative general mental health outcomes among children (g = 0.28, p < 0.001, and k = 21), but of small magnitude. Sleep habits were also changed during the pandemic, as sleep duration significantly increased in children (g = 0.32; p = 0.004, and k = 9). Moreover, results did not differ between children from the general population and those from clinical populations such as children with epilepsy, oncology, neurodevelopmental disorders, or obesity. Effect sizes were larger in European vs. Asian countries. Conclusions: Studies included in this review suggest that children's mental health was generally negatively impacted during the COVID-19 pandemic. More research is needed to understand the long-term effects of the COVID-19 pandemic on children's mental health and the influence of specific risks factors as they evolve over time.
Copyright © 2021 Bussières, Malboeuf-Hurtubise, Meilleur, Mastine, Hérault, Chadi, Montreuil, Généreux, Camden and PRISME-COVID Team.

Entities:  

Keywords:  COVID-19; children; impact; mental health; meta-analysis

Year:  2021        PMID: 34925080      PMCID: PMC8672800          DOI: 10.3389/fpsyt.2021.691659

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


Background

In December 2019, a highly infectious strain of the coronavirus (COVID-19) emerged in China and spread globally within a few months. This led the World Health Organization to declare a global pandemic status (1). In early 2020, several countries implemented lockdown measures, leading to extended school closures, and home lockdown for children and their families. Though lockdown measures were gradually lifted, and some schools were allowed to reopen, children's regular routines were disrupted with the addition of new rules, such as wearing a mask in class or making a transition to online or hybrid schooling (instead of in-person learning). Emerging research has suggested that these various restrictions, as well as the fear of the virus itself, may have caused children to experience negative mental health consequences (2, 3). In non-pandemic contexts, prevalence studies have shown that between 14 and 25% of children experience psychological distress (4). The profound disruptions in children's normal routines associated with school closures and lockdown measures over several months, in addition to the social isolation and loneliness associated with lockdown measures, pose the risk of additional adverse child mental health outcomes on a population level (5). Some children may be more at risk, such as those with a neurodevelopmental disorder or disability (e.g., attention-deficit/hyperactivity disorder [ADHD], autism spectrum disorder [ASD], cerebral palsy), chronic health condition (e.g., diabetes, obesity), or other pre-existing mental health disorder (e.g., anxiety disorder). Namely, these children may be particularly disadvantaged in facing the effects of the pandemic by virtue of its impacts on access to health care resources and support networks (6–8). It is thus crucial to clarify the impact of pandemic-associated public health measures on children's mental health and to identify which children are at greater risk of negative outcomes, in order to support them adequately.

Objectives

The purpose of this study was to examine the impacts of the COVID-19 pandemic on children's mental health. Specifically, the following objectives were pursued: (1) to identify the impacts of the COVID-19 pandemic on the mental health of children between the ages of 5- and 13-years-old, (2) to explore the specific difficulties experienced by children with neurodevelopmental issues or chronic health conditions.

Methods

The general purpose for conducting a systematic review and meta-analyses is to identify and quantitively summarize the available evidence on a specific aspect of chosen topic; consequently, this methodology was deemed the most appropriate for examining emerging evidence related specifically to the mental health of school-aged children.

Eligibility Criteria

To be included in this systematic review, studies had to include: (1) quantitative data pertaining to the impacts of the COVID-19 pandemic on the mental health of children aged 5–13 years-old; (2) cross-sectional or longitudinal designs; and (3) original empirical data. Only published peer-reviewed articles were included. Studies with pre and post measures (longitudinal or cross-sectional designs with retrospective measures) were included in the quantitative meta-analyses. Studies using cross-sectional designs with no retrospective measures were summarized for an overview of COVID mental health impacts. Mean age of children in the sample was used to determine study eligibility in each study; mean ages below 5 years old and above 13 years old were excluded.

Information Sources and Search Strategy

Articles in both French and English, published between January 2020 and June 2021 were searched using the keywords presented in Table 1. Four databases were used: Medline, PsycINFO, ERIC, and Google Scholar. Of note, this study focused solely on the COVID-19 pandemic, as the impacts of other prior pandemic outbreaks (e.g., cholera, flu, HIV, and the plague) were deemed incomparable to the large-scale effects that COVID-19 has brought onto the world.
Table 1

Keywords.

COVID-19 Mental health Children
COVID-19, coronavirus“Mental health” OR psychosocial OR distress OR wellbeing OR anxiety OR “anxiety disorders” OR mood OR anxious OR stress* OR insomnia OR “mood disorders” OR depressi* OR PTSD OR “post-traumatic stress” OR “suicidal thoughts” OR “suicidal attempts” OR “maladaptive behaviors” OR anger OR confusion OR hopelessness OR panic OR phobia OR “emotional distress” OR inattention OR attention OR agitation OR irritability OR behavior* OR conduct OR hyperactiv* OR “non-compliance” OR psychiatric OR psychological OR “adjustment disorder” OR psychosis OR psychopathology OR “internalized disorder*” OR “externalized disorder*Child* OR pediatric OR pediatric OR youth OR kid* OR juvenile
Keywords.

Selection of Sources of Evidence

Three research assistants (G.B., T.M., and M.C.) selected the documents; they first reviewed all papers independently, after partial reading (according to title and abstract), then met with the Principal Investigator (C.C.) to discuss disagreements and revise the selection, if necessary. Subsequently, the selection of documents after full reading was carried out by three research assistants (A.M., G.B., and T.M.). When necessary, the Principal Investigator and the research coordinator (E.H.) were consulted to discuss disagreements and revise the selection.

Data Extraction Process

Three research assistants (A.M., G.B., and T.M.) charted the data from primary studies. The following information was retrieved from primary studies and was noted in the charting grid: study methodology (design, number of participants, and data collection timeline relative to lockdown), country of origin, study population characteristics (age, sex, and children with a disability or a chronic health condition, etc.), study objectives, mental health outcome (e.g., psychological distress, stress, anxiety, depression, and irritability) and on other aspects of health in general (e.g., well-being, physical health, and sleep), as well as quantitative results for calculating effect sizes (t-value from paired t-test, means and standard deviations, etc.). Data collection dates with respect to COVID-19 lockdown were extracted for each study, which could vary according to country and region. Outcomes were subsequently codified into three mental health categories: internalizing problems, externalizing problems, and sleep disturbances (e.g., insomnia). When studies reported outcomes that were a combination of internalized and externalized problems, or measured wellbeing, they were codified as “mental health.” Sleep duration was treated as a separate category, outside of mental health problems. The extraction grid was developed by the research team and the initial charting of three articles was validated by the co-Principal Investigator (C.M.H). Finally, four authors (CC, EH, CMH, and ELB) read and verified the information from all selected documents.

Analytic Approach

Random effect meta-analyses were performed using Comprehensive Meta-Analysis (CMA) 3.0 software (9). A positive effect direction was attributed when outcomes indicated a higher score on symptomology (i.e., greater mental health problems), or a lower score on wellbeing and mental health (i.e., worse mental health). For sleep duration, a positive effect size indicated more hours of sleep per night, whereas a negative effect showed fewer hours than before lockdown. For effect size calculation, the pre-post correlation was extracted from studies when available (10). However, most studies did not report it, in which case researchers used a conservative estimate of 0.5 and conducted sensitivity analyses showing little difference between other correlational values (e.g., r = 0.1 or 0.9). An overall effect size (Hedges's g) was calculated from the effect sizes of the individual studies, with 95% confidence intervals (CI). The random effects approach was used because of the variability in the methodology and measurement scales used between studies (11). A Q-statistic and the I2 statistics were calculated to quantify heterogeneity between effect sizes (12).

Subgroup Analyses

Subgroup analyses were conducted based on five variables: (1) type of outcome (externalized, internalized), (2) population (clinical or general), (3) informant for the dependant variable (child or parent), (4) study design (longitudinal or cross-sectional with a retrospective pre-pandemic measure), and (5) the geographical location in which the study was carried out (America, Asia, Europe, and Middle East). Every subgroup analysis was done using study as a unit of analysis to avoid duplication of participants, excepting for the type of outcome, which was done using subgroups within study as a unit of analysis. Continuous variables (e.g., age of the child) could not be tested through meta-regression due to missing data.

Risk of Bias Across Studies

Publication bias refers to the tendency that studies reporting higher effect sizes are more likely to be published than studies reporting lower effect sizes. Because published literature is more likely to find its way to a meta-analysis, any bias in the literature is likely to be reflected in the meta-analysis (11). To estimate more precisely the possibility of publication bias within our data, a funnel plot was created using the CMA software and the Trim-and-Fill Procedure (13).

Results

The search strategy identified 985 documents, and 71 studies were included, 43 in qualitative synthesis (see Supplementary Material) and 28 studies were included in the quantitative synthesis (meta-analysis; see Figure 1).
Figure 1

PRISMA flow chart showing the number of included studies for the review.

PRISMA flow chart showing the number of included studies for the review.

Description of Included Studies in the Quantitative Synthesis

Study sample size varied between 12 and 8,124 participants; a total of 14 209 participants were included in the 28 studies. All studies indicated the start of lockdown as being either February [e.g., in China (14)] or March 2020 [e.g., in Italy (15); in Spain (16)] and referred to pre-lockdown as the period before February or March 2020. Studies were conducted in various countries: Italy (k = 6), United Kingdom (k = 3), Netherlands (k = 3), Spain (k = 3), Germany (k = 1), Switzerland (k = 1), these studies were codified as being conducted in “Europe”; China (k = 2), Japan (k = 2), South Korea (k = 1), Singapore (k = 1), these studies were codified as being conducted in “Asia”; Israel (k = 1), Turkey (k = 1) which were coded as “Middle East”; Canada (k = 1), United States (k = 1) and Argentina (k = 1) were coded as “America.” Meta-analysis study characteristics are presented in Table 2. Among the 28 studies, three studies included a sample of children at-risk for mental health problems or with a neurodevelopmental disorder such as ASD (17, 18), and five included children with medical or physical diagnoses such as epilepsy and obesity (19–22). Two of these studies also had a control group from the general population (17, 23). The other studies were conducted using general population samples (k = 20). Among the scales used to measure mental health outcomes, the Strength and Difficulties Questionnaire (SDQ) was used the most frequently (k = 7), followed by the Child Behavior Checklist (CBCL; k = 3). The cross-sectional studies are presented in Supplementary Material for a brief qualitative synthesis (k = 43).
Table 2

Characteristics of studies included in the quantitative synthesis.

Study name Country Population n Age (M; sd) Measure Informant Outcome Design
Abawi et al. (19)NetherlandsObesity4010.5PedsQLParentIntLongitudinal
Achterberg et al. (24)NetherlandsGeneral20312.0SDQParentExt, IntLongitudinal
Adegboye et al. (25)United KingdomAt risk for MH14212.0SDQ, SCAREDParentExt, IntLongitudinal
Bentenuto et al. (17)ItalyNDD827.0SDQParentExtRetrospective
Bignardi et al. (26)United KingdomGeneral1659.9SDQ, RCADSParentInt, MH healthLongitudinal
Cellini et al. (15)ItalyGeneral2998.0SDQParentExt, Int, SleepRetrospective
Chen et al. (14)ChinaGeneral53510.3DASS-21ChildIntLongitudinal
Choi et al. (27)South KoreaGeneral1,2369–10*KCYWIChildInt, SleepLongitudinal
Ehrler et al. (23)SwitzerlandPreterm20012.8Kidscreen-27ParentMHLongitudinal
Feinberg et al. (28)United StatesGeneral1089.9SDQParentExt, IntLongitudinal
Francisco et al. (29)ItalyGeneral1,4809.2ParentSleepRetrospective
Ghanamah and Eghbaria-Ghanamah (30)IsraelGeneral3825–11*ParentSleepRetrospective
Gimenez-Dasi et al. (31)SpainGeneral758.6SENAParentExt, IntLongitudinal
Lim et al. (32)SingaporeGeneral3368.0ParentSleepRetrospective
Logan et al. (20)CanadaNeuroInf8713.0ChildSleepLongitudinal
López-Bueno et al. (33)SpainGeneral4599.6ParentSleepRetrospective
Medrano et al. (16)SpainGeneral11312.0ChildSleepLongitudinal
Morgül et al. (34)United KingdomGeneral9277.5ParentSleepRetrospective
Pasca et al. (21)ItalyEpilepsy2313.0CBCLParentIntLongitudinal
Saito et al. (35)ItalyGeneral13511.4WHO-5-JChildMHLongitudinal
Schnaiderman et al. (36)ArgentinaGeneral26711.1ParentSleepRetrospective
Siracusano et al. (18)ItalyASD, Sotos128.5CBCLParentExtLongitudinal
Takahashi and Honda (37)JapanGeneral4,73812.4SDQParentExt, IntLongitudinal
Tanir et al. (38)TurkeyGeneral6113.6CY-BOCSParentMHLongitudinal
van Gorp et al. (22)NetherlandsOncology4074–18*PedsQLParent, childIntLongitudinal
Wunsch et al. (39)GermanyGeneral7524–17*Kidscreen-27ParentMHLongitudinal
Xiang et al. (40)ChinaGeneral8756–12*CDI-SParentIntLongitudinal
Zaccaria et al. (41)ItalyGeneral709.1CBCLParentExt, IntLongitudinal

Age range was provided for studies that did not report mean and standard deviation; ASD, Autism Spectrum Disorder; NDD, Neurodevelopmental Disorders; NeuroInf, Neuroinflammatory; CBCL, Child Behavior Checklist; CDI-S, Child Depression Inventory—Short Form; DASS-21, Depression Anxiety Stress Scale-21; KCYWI, Korean Children and Youth Wellbeing Index; MH, Mental Health; PedsQL, Pediatric Quality of Life Inventory; RCADS, Revised Children's Anxiety and Depression Scale; SCARED, Screen for Child Anxiety Related Disorders; SDQ, Strength and Difficulties Questionnaire; SENA, System of Evaluation of Children and Adolescent.

Characteristics of studies included in the quantitative synthesis. Age range was provided for studies that did not report mean and standard deviation; ASD, Autism Spectrum Disorder; NDD, Neurodevelopmental Disorders; NeuroInf, Neuroinflammatory; CBCL, Child Behavior Checklist; CDI-S, Child Depression Inventory—Short Form; DASS-21, Depression Anxiety Stress Scale-21; KCYWI, Korean Children and Youth Wellbeing Index; MH, Mental Health; PedsQL, Pediatric Quality of Life Inventory; RCADS, Revised Children's Anxiety and Depression Scale; SCARED, Screen for Child Anxiety Related Disorders; SDQ, Strength and Difficulties Questionnaire; SENA, System of Evaluation of Children and Adolescent.

Main Analysis

Among the 28 included longitudinal or retrospective studies, a series of two meta-analyses was conducted with studies which included mental health outcomes (internalizing, externalizing, and sleep disturbances) (k = 21) and studies including sleep duration (k = 9).

Studies Including Mental Health Outcomes

Across all studies with mental health outcomes (k = 21), a small overall effect size of g = 0.276 (95% CI [0.15, 0.41]; p < 0.001) was observed for children's mental health before and during lockdown. This effect indicates an overall worsening of mental health in children across different outcomes (internalizing and externalizing symptoms, well-being, and sleep disturbances), but of small magnitude. As the Q statistics is significant (Q = 1,008,807, p < 0.001), it is pertinent to conduct moderator analysis. Table 3 presents subgroup analyses for mental health studies.
Table 3

Subgroup analyses for mental health studies (k = 21).

Variables k N g Confidence interval Contrast Q' (p)
Lower limit Upper limit
All studies 2110,4250.28***0.150.41
Mental health problems
Internalizing198,9160.21**0.060.37
Externalizing155,7290.14***0.080.21
Population
Clinical48360.15−0.100.40
General1610,0390.30***0.140.45
Clinical vs. General3.60 (0.17)
Design
Longitudinal189,7770.27**0.110.43
Retrospective36480.27*0.150.39
Longitudinal vs. Retrospective0.00 (0.97)
Informant
Child31,9060.57
Parent178,1120.23***
Both14070.07
Child vs. parent5.16 (0.076)
Geographical location
Asia36,8490.06
Europe153,1400.31**
America23750.14
Middle East1610.76***
Asia vs. Europe4.7 (0.03)

p < 0.05;

p < 0.01;

p < 0.001;

p < 0.08.

k, Number of studies; N, Number of participants; g, Hedge's g effect size.

Subgroup analyses for mental health studies (k = 21). p < 0.05; p < 0.01; p < 0.001; p < 0.08. k, Number of studies; N, Number of participants; g, Hedge's g effect size.

Type of Outcome

A small effect size was observed for internalizing symptoms (g = 0.215; 95% CI [0.06, 0.37]; p < 0.001; k = 19) and for externalizing symptoms (g = 0.141 (95% CI [0.08, 0.21]; p < 0.01; k = 15), showing that children demonstrated higher levels of both internalized and externalized symptoms during lockdown. Considering that some participants may be duplicated in these analyses, a contrast analysis was not done to determine whether these two effect sizes are statistically different one from another, as recommended by Lipsey and Wilson (10).

Population Type

Children with a clinical condition (e.g., ADHD, ASD, and epilepsy) did not seem to be affected differently in comparison with children from the general population (Contrast Q' = 3.60; p = 0.166).

Study Design

Effect sizes reported by studies using a longitudinal design (g = 0.27; 95% CI [0.11, 0.44]; p < 0.01; k = 18) did not differ from cross-sectional designs using retrospective measures for the pre pandemic measure (g = 0.27; 95% CI [0.15, 0.39]; p < 0.001; k = 3; Contrast Q'= 0.002; p = 0.97).

Informant

There were larger effect sizes in studies where the child was the informant (g = 0.57; 95% CI [−0.36, 1.50]; p = 0.23; k = 3) in comparison to studies in which the parent as the informant (g = 0.23; 95% CI [−0.11, 0.35]; p < 0.001; k = 17). However, this result is based on a limited number of studies (only three studies had children reporting data) and should be interpreted with caution.

Country

Changes in children's mental health were three times larger for European countries (g = 0.31; 95% CI [0.10, 0.52]; p < 0.01; k = 15) in comparison to Asian countries (g = 0.01; 95% CI [−0.04, 0.15]; p = 0.26; k = 3). This difference is statistically significant (Contrast Q' = 4.7; p = 0.03).

Studies Including Sleep Duration Outcomes

Children's sleep was significantly affected during the COVID-19 lockdown period, with significantly longer sleeping hours during lockdown compared to before (g = 0.324; 95% CI [0.10, 0.55]; p = 0.004; k = 9). Subgroup analysis was not performed due to small number of studies in each subset (<4), according to best practices in meta-analysis (42).

Heterogeneity and Publication Bias

The Q-test for heterogeneity was significant (Q = 1,008,807, p < 0.001). The I2 statistic was used in complement to the Q statistic to quantify the degree of heterogeneity in the aggregated studies, as proposed by Huedo-Medina et al. (43). The I2, which represents the percentage of variation across studies that is due to heterogeneity, was 98.02. Visual observation of the funnel plot (Figure 2) does not show the presence of a publication bias, which is confirmed by the Trim-and-Fill procedure. No outlier was observed in this meta-analysis.
Figure 2

Funnel Plot for publication bias.

Funnel Plot for publication bias.

Discussion

This meta-analysis aimed to identify the impacts of the COVID-19 pandemic on children's mental health and to explore the specific issues experienced by children with neurodevelopmental issues or chronic health conditions. Overall, the quantitative synthesis of longitudinal and retrospective studies suggests that a negative impact of the pandemic was observed on children's mental health, but this impact is of weak magnitude, for both internalized (e.g., anxiety or depression) and externalized symptoms (e.g., conduct disorder, hyperactivity). These results support, to an extent, the large body of cross-sectional studies that have collected data during the pandemic (without pre-pandemic measures) and which report consistently negative outcomes regarding children's mental health during the pandemic. The cross-sectional studies identified in the qualitative section of this review suggest similar conclusions, with a majority of studies (35/43) reporting negative an overall negative impact on mental health associated with the COVID-19 lockdown. Similarly, recently published systematic reviews examining the impact of the pandemic on children's mental health suggest that the lockdown associated with Covid-19 pandemic had a negative impact on children' mental health (44–46). However, the cross-sectional nature of the included studies makes it difficult to draw firm conclusions from these reviews. The present meta-analysis is the first to provide an estimate of the changes in children's mental health symptoms during Covid-19 pandemic by way of a meta-analysis including longitudinal data. Our meta-analysis suggests that the COVID-19 period was associated with weak impact on children's mental health, which contrasts with a recent meta-analysis that has looked at the prevalence of anxiety and depression among children and teenagers during the pandemic (47). These authors have synthesized prevalence data reported in cross-sectional studies and have observed a prevalence of anxiety (20.5%) and depression (25.2%) two times higher than prepandemic estimates. If we look specifically at the well-being of children having special needs, the conclusions remain the same. Indeed, a subgroup analysis comparing clinical samples and general population samples revealed that having a neurodevelopmental disorder or chronic health condition did not place these children at higher risk of developing mental health symptoms with to the COVID-19 pandemic lockdown measures. This conclusion may seem surprising, considering that they stand in contrast to Panda et al.'s (46) systematic review's conclusions. Given that our results arise from a small subset of studies with mental health outcomes (four studies included clinical samples), and thus need to be interpreted with caution. In addition, these four samples are very heterogeneous and include children with epilepsy, ASD, obesity, who were both preterm and with other neurodevelopmental disorders. As some authors have highlighted, children with psychiatric or neurodevelopmental disorders do not necessary show homogeneous responses to the pandemic (48). For example, Cost et al. (48) observed that whereas those with social anxiety or learning disorders showed reduced mental health symptoms (reduced anxiety and irritability), those with ADHD or ASD showed greater irritability and lower mood. These authors hypothesized that children with anxiety or learning disorders might have felt relief from the lockdown situation, while those with ADHD or ASD most likely suffered from a loss of structure and fewer social interactions (48). In a future meta-analysis including a larger number of studies, clinical samples could be grouped to achieve more homogeneous subgroups. Moreover, this meta-analysis shows a trend toward a larger effect size when mental health effects are self-reported by children themselves. This result should be interpreted with caution given the small number of studies with self-report measures but could be the object of further studies with larger samples sizes to account for children's perspectives on changes in their own mental health. Finally, the impact of the pandemic on children's mental health is three times larger in studies conducted in European countries, in comparison with studies conducted in Asian Countries. This result does not corroborate the conclusions reported in other reviews, and in fact is at the opposite of conclusions stated by Panda et al. (46) who observed a higher prevalence of psychological morbidities in Asian countries in comparison to European countries like Spain. Once again, caution is warranted in drawing conclusions from our subgroup analysis since this analysis is based on only three studies conducted in Asian countries.

Sleep Duration

Our study revealed significant changes in sleep duration during the COVID pandemic. The clinical significance of these changes remains unknown given that sleep can be both an indicator of healthy lifestyle behaviors and poor mental health (e.g., in the case of a depressive disorder). Additional studies are needed focusing on sleep quality instead of sleep duration, to draw conclusions on the associations between the COVID-19 pandemic and children's sleep-related outcomes.

Limitations

Although this meta-analytic review includes longitudinal data that allows to shed light on the impact of the pandemic on children's mental health, most studies relied on parents' perception about their children's psychological state. As parental distress may interfere with their report of their children's functioning, future work in which the perspective of children is incorporated is strongly recommended, especially with preliminary data from this meta-analysis suggesting that effect sizes reported by children could be larger than parent's report. Another limitation of the present meta-analysis is the heterogeneity in the measurement tools used in the primary studies included. In addition, it must be highlighted that these instruments allow to quantify symptoms but not to concern clinical diagnosis. Finally, another limitation is the fact that the data collections in included studies varied from 3 weeks to 6 months with respect to the implementation of public health measures; therefore, it is difficult to confirm a direct link between the application of the measures and children's mental health. Rigorous, population-based longitudinal studies correlated with public health measures, using large samples and standardized tools would address these gaps. Finally, future research should include longer follow-ups to address the long-term consequences of the Covid-19 pandemic on children's mental health.

Conclusion

In sum, studies included in this meta-analysis suggest that changes seen in children's mental health during the early phases of the COVID-19 pandemic period, which included the application of several public health measures were relatively small. More research is needed to improve our understanding of the long-term impacts of the COVID-19 pandemic on children's mental health, especially with regards to the identification of protective factors found in children who may have been less affected by the pandemic. Several questions remain unanswered including which characteristics of living environments can positively or negatively affect children's capacity to adapt to major public health crises such as the COVID-19 pandemic. Future research should include self-reported measures completed by children themselves, and follow not only mental health outcomes through time, but also developmental, learning, academic and eventually work-related outcomes as the pandemic and post-pandemic period unfolds. It is crucial to develop a better understanding of children's psychological needs during this pandemic, to elaborate comprehensive and evidence-based interventions to support children and their families through these unprecedented times.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author Contributions

E-LB wrote the manuscript and took part in all steps of the research project. CM-H made substantial revisions to the manuscript. CC and CM-H were co-PIs on this project and obtained funding for it. AM contributed to the analyses and in writing the manuscript. TM, EH, NC, MM, MG, and the PRISME-COVID Team revised the submitted manuscript and were involved in all steps of the research project. All authors contributed to the article and approved the submitted version.

Funding

This study was supported by CIHR (No. 171716).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  39 in total

1.  Understanding why the COVID-19 pandemic-related lockdown increases mental health difficulties in vulnerable young children.

Authors:  Dolapo Adegboye; Ffion Williams; Stephan Collishaw; Katherine Shelton; Kate Langley; Christopher Hobson; Daniel Burley; Stephanie van Goozen
Journal:  JCPP Adv       Date:  2021-04-07

2.  Prevalence of clinical-level emotional/behavioral problems in schoolchildren during the coronavirus disease 2019 pandemic in Japan: A prospective cohort study.

Authors:  Fumito Takahashi; Hideo Honda
Journal:  JCPP Adv       Date:  2021-04-28

3.  Changes in lifestyle behaviours during the COVID-19 confinement in Spanish children: A longitudinal analysis from the MUGI project.

Authors:  María Medrano; Cristina Cadenas-Sanchez; Maddi Oses; Lide Arenaza; Maria Amasene; Idoia Labayen
Journal:  Pediatr Obes       Date:  2020-09-24       Impact factor: 4.000

4.  Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown.

Authors:  Giacomo Bignardi; Edwin S Dalmaijer; Alexander L Anwyl-Irvine; Tess A Smith; Roma Siugzdaite; Stepheni Uh; Duncan E Astle
Journal:  Arch Dis Child       Date:  2020-12-09       Impact factor: 3.791

5.  Perceived stress as mediator for longitudinal effects of the COVID-19 lockdown on wellbeing of parents and children.

Authors:  Michelle Achterberg; Simone Dobbelaar; Olga D Boer; Eveline A Crone
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

6.  Psychological Symptoms and Behavioral Changes in Children and Adolescents During the Early Phase of COVID-19 Quarantine in Three European Countries.

Authors:  Rita Francisco; Marta Pedro; Elisa Delvecchio; Jose Pedro Espada; Alexandra Morales; Claudia Mazzeschi; Mireia Orgilés
Journal:  Front Psychiatry       Date:  2020-12-03       Impact factor: 4.157

7.  Sleep and Psychological Difficulties in Italian School-Age Children During COVID-19 Lockdown.

Authors:  Nicola Cellini; Elisa Di Giorgio; Giovanna Mioni; Daniela Di Riso
Journal:  J Pediatr Psychol       Date:  2021-02-19

8.  Socio-economic inequalities in social network, loneliness and mental health during the COVID-19 pandemic.

Authors:  Rusi Jaspal; Glynis M Breakwell
Journal:  Int J Soc Psychiatry       Date:  2020-12-07

9.  Mental health in Japanese children during school closures due to the COVID-19.

Authors:  Mari Saito; Yutaka Kikuchi; Alan Kawarai Lefor; Masaru Hoshina
Journal:  Pediatr Int       Date:  2021-11-22       Impact factor: 1.617

View more
  6 in total

1.  Quality of Life and Mental Health in Children and Adolescents after the First Year of the COVID-19 Pandemic: A Large Population-Based Survey in South Tyrol, Italy.

Authors:  Verena Barbieri; Christian Josef Wiedermann; Anne Kaman; Michael Erhart; Giuliano Piccoliori; Barbara Plagg; Angelika Mahlknecht; Dietmar Ausserhofer; Adolf Engl; Ulrike Ravens-Sieberer
Journal:  Int J Environ Res Public Health       Date:  2022-04-25       Impact factor: 4.614

2.  Mental Health and Health-Related Quality of Life in German Adolescents after the Third Wave of the COVID-19 Pandemic.

Authors:  Justine Hussong; Eva Möhler; Anna Kühn; Markus Wenning; Thomas Gehrke; Holger Burckhart; Ulf Richter; Alexandra Nonnenmacher; Michael Zemlin; Thomas Lücke; Folke Brinkmann; Tobias Rothoeft; Thorsten Lehr
Journal:  Children (Basel)       Date:  2022-05-25

3.  Is Endemicity a Solution for the COVID-19 Pandemic? The Four E's Strategy for the Public Health Leadership.

Authors:  Leonardo Villani; Maria Rosaria Gualano; Walter Ricciardi
Journal:  Front Public Health       Date:  2022-06-28

4.  Teachers' emotional exhaustion before and during the COVID-19 pandemic: Neither emotional exertion nor vacation feeling.

Authors:  Victoria Bleck; Frank Lipowsky
Journal:  Front Psychol       Date:  2022-08-08

5.  Adolescent social emotional skills, resilience and behavioral problems during the COVID-19 pandemic: A longitudinal study in three European countries.

Authors:  Baiba Martinsone; Ieva Stokenberga; Ilze Damberga; Inga Supe; Celeste Simões; Paula Lebre; Lúcia Canha; Margarida Santos; Anabela Caetano Santos; Ana Marta Fonseca; Dória Santos; Margarida Gaspar de Matos; Elisabetta Conte; Alessia Agliati; Valeria Cavioni; Sabina Gandellini; Ilaria Grazzani; Veronica Ornaghi; Liberato Camilleri
Journal:  Front Psychiatry       Date:  2022-08-01       Impact factor: 5.435

Review 6.  The Impact of COVID-19-Related Living Restrictions on Eating Behaviours in Children and Adolescents: A Systematic Review.

Authors:  Lucy Brakspear; Daniella Boules; Dasha Nicholls; Victoria Burmester
Journal:  Nutrients       Date:  2022-09-04       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.